<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181225042118N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-09-21</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Fateh Massage on Low Back Pain</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the Effect of an Iranian Massage (Fateh Method) on Pain and Disability of Patients Suffering from Chronic Low Back Pain with Physiotherapy and Acupuncture</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-09-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/41740</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>chronic low back pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: patients are selected according to inclusion criteria and examined by a doctor. After elimination of patients with exclusion criteria, the research is explained to patients and the ones who accept to be part of the study, fill the written consent form out. In this group 10 sessions of massage with the special method of Fateh -deep fascial release- is done. lifestyle and exercise are taught to the patients to relieve pain and exercise instructions are given to each. Diclofenac is also given to patients to use if needed (one 100 mg Tablet of Iran Najou pharmacy company) and write down the exact number of tablets carefully. Intervention 2: Intervention group 2: patients are selected according to inclusion criteria and examined by a doctor. After elimination of patients with exclusion criteria, the research is explained to patients and the ones who accept to be part of the study, fill the written consent form out. Acupuncture patients receive 10 sessions of therapy each 20 minutes, twice a week. lifestyle and exercise are taught to the patients to relieve pain and exercise instructions are given to each. Diclofenac is also given to patients to use if needed (one 100 mg Tablet of Iran Najou pharmacy company) and write down the exact number of tablets carefully. Intervention 3: Control group: patients are selected according to inclusion criteria and examined by a doctor. After elimination of patients with exclusion criteria, the research is explained to patients and the ones who accept to be part of the study, fill the written consent form out. Patients of physiotherapy group receive 10 sessions of standard physiotherapy for chronic low back pain. lifestyle and exercise are taught to the patients to relieve pain and exercise instructions are given to each. Diclofenac is also given to patients to use if needed (one 100 mg Tablet of Iran Najou pharmacy company) and write down the exact number of tablets carefully.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is there is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Parva Namiranian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 6, Entesariyeh st., 2nd alley, north karegar street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1413915518</zip>
        <telephone>+98 21 8800 3198</telephone>
        <email>p-namiranian@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mohammad Hossein Ayati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North sarparast, Ahmadieh health building</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1417653761</zip>
        <telephone>+98 21 8897 6527</telephone>
        <email>mh-ayati@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Chronic low back pain without paresthesis and radicular pain and any specific pathology
Pain more than 3 months
Confirmation of low back pain and clinical examination by expert to exclude pathologies</inclusion_criteria>
      <agemin>19 years</agemin>
      <agemax>69 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy or breastfeeding
History of surgery due to low back pain
Red flags that need more investigations or surgery
Ankylosing Spondylitis
Neuropathy or neurologic problems in physical examination
Severe untreated Scoliosis
Infection in low back or spinal cord
Acute radiculopathy
Menthal problems
Acute trauma
Rheumatoid inflammatory disorders
Uncontrolled Hypertension or Diabetus Mellitus
Digestive system problems including stomach pain or ulcer, IBD
Low back pain due to Uterus conditions
Signs of weakness or Emtela
Use of Digoxin, Warfarin; Heparin
Addiction to alcohol or drugs and so on
History of epidural or transforaminal injection of anesthetics or corticosteroids during 4 weeks prior to start of treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Loin pain, Low back strain, Lumbago NOS</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: patients are selected according to inclusion criteria and examined by a doctor. After elimination of patients with exclusion criteria, the research is explained to patients and the ones who accept to be part of the study, fill the written consent form out. In this group 10 sessions of massage with the special method of Fateh -deep fascial release- is done. lifestyle and exercise are taught to the patients to relieve pain and exercise instructions are given to each. Diclofenac is also given to patients to use if needed (one 100 mg Tablet of Iran Najou pharmacy company) and write down the exact number of tablets carefully.</i_keyword>
      <i_keyword>Intervention group 2: patients are selected according to inclusion criteria and examined by a doctor. After elimination of patients with exclusion criteria, the research is explained to patients and the ones who accept to be part of the study, fill the written consent form out. Acupuncture patients receive 10 sessions of therapy each 20 minutes, twice a week. lifestyle and exercise are taught to the patients to relieve pain and exercise instructions are given to each. Diclofenac is also given to patients to use if needed (one 100 mg Tablet of Iran Najou pharmacy company) and write down the exact number of tablets carefully.</i_keyword>
      <i_keyword>Control group: patients are selected according to inclusion criteria and examined by a doctor. After elimination of patients with exclusion criteria, the research is explained to patients and the ones who accept to be part of the study, fill the written consent form out. Patients of physiotherapy group receive 10 sessions of standard physiotherapy for chronic low back pain. lifestyle and exercise are taught to the patients to relieve pain and exercise instructions are given to each. Diclofenac is also given to patients to use if needed (one 100 mg Tablet of Iran Najou pharmacy company) and write down the exact number of tablets carefully.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain level due to low back pain. Timepoint: Before starting study, after the intervention, one month after intervention. Method of measurement: Visual Analogue Scale questionnaire.</prim_outcome>
      <prim_outcome>Disability level due to low back pain. Timepoint: Before starting study, after the intervention, one month after intervention. Method of measurement: Roland Morris disability questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-12-15</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Central building of Tehran University of Medical Sciences, Ghods street crossing Keshavarz Bld Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
